Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1018-1025.
Prepublished online as a Blood First Edition Paper on September 26, 2006; DOI 10.1182/blood-2006-05-022301.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-05-022301v1
109/3/1018    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasirer-Friede, A.
Right arrow Articles by Shattil, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasirer-Friede, A.
Right arrow Articles by Shattil, S. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 9, 2006
Accepted September 9, 2006

ADAP is required for normal {alpha}IIb{beta}3 activation by VWF/GP Ib-IX-V and other agonists

Ana Kasirer-Friede*, Paul Barry Moran, Jennifer Nagrampa-Orje, Ken Swanson, Zaverio M. Ruggeri, Burkhart Schraven, Benjamin G. Neel, Gary A. Koretzky, and Sanford J. Shattil

Dept of Medicine, University of California San Diego, La Jolla, CA, United States
Dept of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, CA, United States
Dept of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
Institute of Immunology, University of Magdeburg, Magdeburg, Germany
Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, United States

* Corresponding author; email: akasirer{at}ucsd.edu.

Interaction between von Willebrand factor (VWF) and platelet GP Ib-IX-V is required for hemostasis, in part because intracellular signals from VWF/GP Ib-IX-V activate the ligand-binding function of integrin {alpha}IIb{beta}3. Since they also induce tyrosine phosphorylation of the ADAP adapter, we investigated ADAP's role in GP Ib-IX-V signal transduction. Fibrinogen or ligand-mimetic POW-2 Fab binding to {alpha}IIb{beta}3 was stimulated by adhesion of ADAP+/+ murine platelets to dimeric VWF A1A2, but was significantly reduced in ADAP-/- platelets (P < 0.01). {alpha}IIb{beta}3 activation by ADP or a Par4 thrombin receptor agonist was also decreased in ADAP-/- platelets. ADAP stabilized the expression of another adapter, SKAP-HOM, via interaction with latter's SH3 domain. However, no abnormalities in {alpha}IIb{beta}3 activation were observed in SKAP-HOM-/- platelets, which express normal ADAP levels, further implicating ADAP as a modulator of {alpha}IIb{beta}3 function. Under shear flow conditions over a combined matrix of VWF A1A2 and fibronectin to test interactions involving GP Ib-IX-V and {alpha}IIb{beta}3, respectively, ADAP-/- platelets displayed reduced {alpha}IIb{beta}3-dependent stable adhesion. Furthermore, ADAP-/- mice demonstrated increased re-bleeding from tail wounds. These studies establish ADAP as a necessary component of inside-out signaling pathways that couple GP Ib-IX-V and other platelet agonist receptors to {alpha}IIb{beta}3 activation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. G. Baker, C. J. Hsu, D. Lee, M. S. Jordan, J. S. Maltzman, D. A. Hammer, T. Baumgart, and G. A. Koretzky
The Adapter Protein SLP-76 Mediates "Outside-In" Integrin Signaling and Function in T Cells
Mol. Cell. Biol., October 15, 2009; 29(20): 5578 - 5589.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Wang, B. Wei, G. Bismuth, and C. E. Rudd
SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility
PNAS, July 28, 2009; 106(30): 12436 - 12441.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Prevost, J. V. Mitsios, H. Kato, J. E. Burke, E. A. Dennis, T. Shimizu, and S. J. Shattil
Group IVA cytosolic phospholipase A2 (cPLA2{alpha}) and integrin {alpha}IIb{beta}3 reinforce each other's functions during {alpha}IIb{beta}3 signaling in platelets
Blood, January 8, 2009; 113(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Dittrich, I. Birschmann, S. Mietner, A. Sickmann, U. Walter, and T. Dandekar
Platelet Protein Interactions: Map, Signaling Components, and Phosphorylation Groundstate
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1326 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Varga-Szabo, I. Pleines, and B. Nieswandt
Cell Adhesion Mechanisms in Platelets
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 403 - 412.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020